Atlas Trials

Evaluation of ReX-C® System for Medication Adherence in Oncology Patients Taking Oral Oncolytics

Clinical trial NCT04091711 · SUSPENDED

Trial details

NCT number
NCT04091711
Sponsor
Dosentrx Ltd.
Status
SUSPENDED
Phase
Not Applicable
Study type
INTERVENTIONAL
OncologyAdherence, MedicationSide Effect
Start date
2020-04-21
Primary completion
2022-12-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.